Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Alseroxylon

Base Information Edit
  • Chemical Name:Alseroxylon
  • CAS No.:8001-95-4
  • Deprecated CAS:11006-60-3
  • Molecular Formula:C11H28ClN5O
  • Molecular Weight:281.8259
  • Hs Code.:
  • European Community (EC) Number:607-982-5
  • NSC Number:147003
  • DSSTox Substance ID:DTXSID00965206
  • Wikipedia:Colestipol
  • Wikidata:Q3294635
  • NCI Thesaurus Code:C81540
  • RXCUI:2685
  • Mol file:8001-95-4.mol
Alseroxylon

Synonyms:Alkaloids, Monoterpenoid Indole;Alkaloids, Rauvolfia;Alkaloids, Rauwolfia;Alkaloids, Secologanin Indole;Alkaloids, Secologanin Tryptamine;Alkaloids, Terpenoid Indole;Alseroxylon;Derivatives, Strictosidine;Indole Alkaloids, Monoterpenoid;Indole Alkaloids, Secologanin;Indole Alkaloids, Terpenoid;Monoterpenoid Indole Alkaloids;Rauvolfia Alkaloids;Rauwolfia Alkaloids;Secologanin Indole Alkaloids;Secologanin Tryptamine Alkaloids;Strictosidine Derivatives;Terpenoid Indole Alkaloids;Tryptamine Alkaloids, Secologanin;Yohimbans

Suppliers and Price of Alseroxylon
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • American Custom Chemicals Corporation
  • ALSEROXYLON 95.00%
  • 5MG
  • $ 504.74
Total 5 raw suppliers
Chemical Property of Alseroxylon Edit
Chemical Property:
  • Boiling Point:341.5 °C at 760 mmHg 
  • Flash Point:185 °C 
  • Density:g/cm3 
  • Hydrogen Bond Donor Count:5
  • Hydrogen Bond Acceptor Count:6
  • Rotatable Bond Count:11
  • Exact Mass:281.1982382
  • Heavy Atom Count:18
  • Complexity:117
Purity/Quality:

99% *data from raw suppliers

ALSEROXYLON 95.00% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Drug Classes:Antilipemic Agents
  • Canonical SMILES:C1C(O1)CCl.C(CNCCNCCNCCN)N
  • Recent ClinicalTrials:An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Post RFQ for Price